On December 25, China's National Medical Products Administration (NMPA) issued the "Regulations on the Management of Medical Device Export Sales Certification" (hereinafter referred to as the "Regulations"), which will take effect on May 1, 2026.

The Regulations represent a key initiative by the NMPA to implement the State Council's guidelines on deepening reforms in drug and medical device supervision to promote high-quality development in the pharmaceutical industry. The policy aims to strongly support medical device exports and optimize administrative services for issuing export sales certifications.

The implementation of these Regulations is expected to provide broader support and more convenient services for the export of domestic medical devices, accelerating their global expansion and contributing to worldwide public health.

(Note: References to specific media outlets and editors have been omitted as per guidelines.)